|
|
Article: Weighting for Godot: the wait for a weight loss bioactive marvel demands patience, risk tolerance, and investment, while many industrial players prefer to eschew patience and mitigate risk by resigning to commodity platforms that are often unsustainable.(PROPRIETARY PERSPECTIVES)
- Article from:
- Nutraceuticals World
- Article date:
- October 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 Rodman Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Oh the multinational obsession with weight loss--a prodigious consumer base enduring unmet or underserved needs, an increasingly slothful population obsessed with ingestive hedonism, and an evangelism-driven continuum of therapeutic and prophylactic promises. A self-perpetuating machine with food, beverage, and dietary supplement value chain contingencies either reinforcing the corpulence and complacency with sedentary life options and/or reinforcing the hope that an easy and effective solution does indeed exist.
The imminent entrance of the drug orlistat, a lipase inhibitor (and thus a fat-derived calorie absorption antagonist), onto the prescription-free ...
Related newspaper, magazine, and journal articles:
|
|
Article: Mexico, United States, Canada combat weight loss ...
M2 Presswire;
October 25, 2005 ;
700+ words
... ... States, Canada combat weight loss fraud; Over 700 compliance ... effective in promoting weight loss, the best proven method ... MUCH group, the MUCH weight loss initiative and the Trilateral ... website at: www.hc-sc.gc.ca/fn-an ...
|
|